RF energy console including method for vessel sealing
US-9161813-B2 · Oct 20, 2015 · US
US12440262B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-12440262-B2 |
| Application number | US-202318338594-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jun 21, 2023 |
| Priority date | May 9, 2019 |
| Publication date | Oct 14, 2025 |
| Grant date | Oct 14, 2025 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Apparatus and associated methods relate to controlling electrical power of an electrotherapeutic signal that is provided to a biological tissue engaged by an electrosurgical instrument during a medical procedure. Electrical power—a product of a voltage difference across and an electrical current conducted by the engaged biological tissue—is controlled according to a therapeutic schedule. The electrotherapeutic schedule can be reduced or terminated in response to a termination criterion being met. In some examples, the termination criterion is a current characteristic, such as, for example, a decrease in current conducted by the engaged biological tissue. In some examples, the termination criterion is a biological tissue resistance characteristic, such as, for example, an increase in the biological tissue resistance that exceeds a predetermined delta resistance value.
Opening claim text (preview).
The invention claimed is: 1. A surgical generator configured to generate and provide controlled electrical power of a therapeutic signal to biological tissue in electrical communication with an instrument, the surgical generator comprising: a control circuit in communication with an electrical-energy source, the electrical-energy source electrically coupled to the instrument and configured to generate the therapeutic signal, the control circuit configured to: control the electrical power of the therapeutic signal provided to the biological tissue during a portion of a non-sealing therapeutic phase according to a therapeutic plan by increasing the electrical power as a function of resistance, wherein the electrical power decreases to a non-zero level between the non-sealing therapeutic phase and a subsequent therapeutic phase. 2. The surgical generator of claim 1 , wherein the control circuit is configured to: control a voltage of the therapeutic signal provided to the biological tissue during a portion of a drying phase according to the therapeutic plan. 3. The surgical generator of claim 2 , wherein the control circuit is configured to: monitor the voltage of the therapeutic signal; and maintain the voltage when the voltage meets a voltage threshold. 4. The surgical generator of claim 1 , wherein the control circuit is configured to: control the electrical power of the therapeutic signal provided to the biological tissue during the portion of the therapeutic phase using a pre-defined power curve. 5. The surgical generator of claim 4 , wherein the pre-defined power curve includes a linear portion. 6. The surgical generator of claim 4 , wherein the pre-defined power curve includes two or more linear portions. 7. A method of delivering controlled electrical power of a therapeutic signal to biological tissue in electrical communication with an instrument, the method comprising: generating, using an electrical-energy source electrically coupled to the instrument, the therapeutic signal; and controlling the electrical power of the therapeutic signal provided to the biological tissue during a portion of a non-sealing therapeutic phase according to a therapeutic plan by increasing the electrical power as a function of resistance or current, wherein the electrical power decreases to a non-zero level between the non-sealing therapeutic phase and a subsequent therapeutic phase. 8. The method of claim 7 , comprising: controlling a voltage of the therapeutic signal provided to the biological tissue during a portion of a drying phase according to the therapeutic plan. 9. The method of claim 8 , comprising: monitoring the voltage of the therapeutic signal; and maintaining the voltage when the voltage meets a voltage threshold. 10. The method of claim 7 , comprising: controlling the electrical power of the therapeutic signal provided to the biological tissue during the portion of the therapeutic phase using a pre-defined power curve. 11. The method of claim 10 , wherein the pre-defined power curve includes a linear portion. 12. The method of claim 11 , wherein the pre-defined power curve includes two or more linear portions. 13. The method of claim 11 , wherein controlling the electrical power of the therapeutic signal provided to the biological tissue during the portion of the non-sealing therapeutic phase according to the therapeutic plan by increasing the electrical power as a function of resistance or current includes: controlling the electrical power of the therapeutic signal provided to the biological tissue during the portion of the non-sealing therapeutic phase according to the therapeutic plan by increasing the electrical power as a function of current. 14. The method of claim 13 , wherein the function of current is a function of an instantaneous measured change in current. 15. The method of claim 14 , wherein the function of the instantaneous measured change in current is a linear function. 16. The method of claim 11 , wherein controlling the electrical power of the therapeutic signal provided to the biological tissue during the portion of the non-sealing therapeutic phase according to the therapeutic plan by increasing the electrical power as a function of resistance or current includes: controlling the electrical power of the therapeutic signal provided to the biological tissue during the portion of the non-sealing therapeutic phase according to the therapeutic plan by increasing the electrical power as a function of resistance. 17. A surgical generator configured to generate and provide controlled electrical power of a therapeutic signal to biological tissue in electrical communication with an instrument, the surgical generator comprising: a control circuit in communication with an electrical-energy source, the electrical-energy source electrically coupled to the instrument and configured to generate the therapeutic signal, the control circuit configured to: control the electrical power of the therapeutic signal provided to the biological tissue during a portion of a non-sealing therapeutic phase according to a therapeutic plan by increasing the electrical power as a function of current, wherein the electrical power decreases to a non-zero level between the non-sealing therapeutic phase and a subsequent therapeutic phase. 18. The surgical generator of claim 17 , wherein the function of current is a function of an instantaneous measured change in current. 19. The surgical generator of claim 17 , comprising: controlling the electrical power of the therapeutic signal provided to the biological tissue during the portion of the therapeutic phase using a pre-defined power curve. 20. The surgical generator of claim 19 , wherein the pre-defined power curve includes a linear portion.
using more than two electrodes on a single probe · CPC title
Voltage · CPC title
Temperature · CPC title
pulsed · CPC title
Probes having pivoting end effectors, e.g. forceps · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.